Jessica Sachs - 30 Jun 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Medical Officer
Signature
/s/ Ryan A. Murr, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
30 Jun 2022
Net transactions value
+$4,600
Form type
4
Filing time
01 Jul 2022, 09:19:06 UTC
Previous filing
27 Jan 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COGT Common Stock Award $4,600 +622 $7.40 622 30 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).